This case underscores the importance of precise molecular diagnosis in guiding therapeutic strategies and provides a valuable reference for clinical decision-making in EGFR-positive NSCLC cases with atypical mutations. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.